Pfizer Net Income From Continuing Ops Over Time
| PFE Stock | EUR 23.37 0.05 0.21% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Pfizer Performance and Pfizer Correlation. Pfizer |
Cross Equities Net Income From Continuing Ops Analysis
Compare Pfizer Inc and related stocks such as Boston Scientific Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX | (119 M) | (119 M) | (119 M) | (119 M) | (119 M) | (239 M) | 347 M | 105 M | 1.7 B | 4.7 B | (82 M) | 1 B | 698 M | 1.6 B | 1.8 B | 2.1 B | 1.2 B |
Pfizer Inc and related stocks such as Boston Scientific Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Pfizer Inc | PFE |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 66 Hudson Boulevard |
| Exchange | Frankfurt Exchange |
EUR 23.37
Check out Pfizer Performance and Pfizer Correlation. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Pfizer technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.